Topical treatment activates immune system to clear precancerous skin lesions
A combination of two FDA-approved drugs - a topical chemotherapy and an immune-system-activating compound - was able to rapidly clear actinic keratosis lesions from patients participating in a clinical trial. Standard treatment ...
Dec 19, 2016
0
211